$170.12
-0.0900 (-0.0529%)
At Close: Aug 04, 2026
Here's Why You Should Retain BD (BDX) Stock in Your Portfolio
02:18pm, Thursday, 24'th Mar 2022
Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and strategic deals.
7 Reddit Stocks Likely to Withstand Any Recession in 2022
07:06pm, Tuesday, 22'nd Mar 2022
These Reddit stocks come from a range of industries, including pharmaceuticals and retailers, and can easily withstand market turmoil. The post 7 Reddit Stocks Likely to Withstand Any Recession in 202
Becton, Dickinson: Low Volatility Is A Strength In The Current Market
07:52pm, Thursday, 17'th Mar 2022
We expect the interventional segment to continue maintaining its high growth as Becton, Dickinson focuses on transformational solutions.
5 Low-Vol Dividend Aristocrats to Survive a Stormy Market
02:42pm, Wednesday, 16'th Mar 2022
Turmoil in the stock market has many investors looking for ways to manage risk. If your goal is safety and reliable income, a great starting point is the Dividend Aristocrats, a group of high-quality
Becton, Dickinson and Company (BDX) Investor Presentation - Slideshow
03:35pm, Saturday, 12'th Mar 2022 Seeking AlphaIHI: A Standout Performer With Equally Strong Future Growth Prospects
05:42am, Saturday, 05'th Mar 2022 Kwhen FinanceIHI: A Standout Performer With Equally Strong Future Growth Prospects
12:42am, Saturday, 05'th Mar 2022
IHI: A Standout Performer With Equally Strong Future Growth Prospects
$4.52 Billion Worldwide Flow Cytometry Industry to 2031 - Identify Growth Segments for Investment
12:08pm, Friday, 04'th Mar 2022 Benzinga
Dublin, March 04, 2022 (GLOBE NEWSWIRE) -- The "Flow Cytometry Global Market Report 2022, By Type, By Technology, By End User, By Application" report has been added to ResearchAndMarkets.com''s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the global flow cytometry market. The report gives a guide to the flow cytometry market which will be shaping and changing our lives over the next ten years and beyond, including the market''s response to the challenge of the global pandemic Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates. Create regional and country strategies on the basis of local data and analysis. Identify growth segments for investment. Outperform competitors using forecast data and the drivers and trends shaping the market.
Scared of a Bear Market? Buy This Rock-Solid Stock Now
11:11am, Saturday, 26'th Feb 2022
It's holding up without breaking a sweat.
Upcoming Ex-Dividend Dates: March 1-9, 2021
09:00am, Saturday, 26'th Feb 2022
Upcoming Ex-Dividend Dates: March 1-9, 2021
Becton Dickinson (BDX) Crossed Above the 20-Day Moving Average: What That Means for Investors
11:35am, Thursday, 24'th Feb 2022
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
Here's Why You Should Retain BD (BDX) Stock in Your Portfolio
01:06pm, Wednesday, 23'rd Feb 2022
Investors continue to be optimistic about BD (BDX) owing to its slew of regulatory approvals and strategic deals.
Riding The Stock Waves: Update On The Medical Devices Sector
08:00am, Monday, 21'st Feb 2022
Riding The Stock Waves: Update On The Medical Devices Sector
Global Chemotherapy Devices Market to Reach USD 23.12 Billion by 2028 - Powered by Increasing Prevalence of Cancer Vantage Market Research
07:57am, Monday, 21'st Feb 2022 Benzinga
WASHINGTON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Chemotherapy Devices Market finds that increasing prevalence of cancer is expediting market growth. Primarily driven by increasing cardiovascular surgeries and diagnostics, the total Global Chemotherapy Devices Market is estimated to reach USD 23.12 Billion by 2028 . The Market stood at a revenue of USD 11.54 Billion in the year 2021, and is expected to exhibit a Compound Annual Growth Rate (CAGR) of 7.5%. Furthermore, the increase in technological advancements is also anticipated to augment the growth of the Global Chemotherapy Devices Market, states Vantage Market Research, in a report, titled " Chemotherapy Devices Market by Product (Catheter, Cannula, Pump, Others), by Application (Hospital, Clinics, Home Care), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)". Click Here To Access The Free Sample Report @ https://www.vantagemarketresearch.com/chemotherapy-devices-market-1310/request-sample (The Free Sample Of This Report Is Readily Available On Request).
Molecular Diagnostics Market is Expected to Grow at a Substantial CAGR of 9.21% and is Contemplated to Reach USD 16.12 Billion by 2026, Estimates DelveInsight
06:00pm, Monday, 14'th Feb 2022 Benzinga
Las Vegas, USA, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Molecular Diagnostics Market is Expected to Grow at a Substantial CAGR of 9.21% and is Contemplated to Reach USD 16.12 Billion by 2026, Estimates DelveInsight Molecular Diagnostics Market is contemplated to witness huge demand in the upcoming years due to rising infectious diseases and their diagnosis, the presence of global as well as regional manufacturers active in developing the Molecular Diagnostic products such as Qiagen, Roche, Molbio Diagnostics Pvt. Ltd., among others. Also, improving healthcare infrastructure, government initiatives in raising awareness regarding molecular diagnosis will contribute to the Molecular Diagnostics market growth in these regions. DelveInsight''s Molecular Diagnostics Market Insights and Forecast report provides the current and forecast Molecular Diagnostics Market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Molecular Diagnostics Market.
Sign In
Buy BDX